Parallel Increase in Urinary Excretion Rates of Immunoglobulin G, Ceruloplasmin, Transferrin, and Orosomucoid in Normoalbuminuric Type 2 Diabetic Patients

Diabetes Care

Volumn 27, Issue 5, 2004, Pages 1176-1181

  Narita, Takuma ^a   Sasaki, Hiroshi ^a   Hosoba, Mihoko ^a   Miura, Takeshi ^a   Yoshioka, Naomi ^a   Morii, Tsukasa ^a   Shimotomai, Takashi ^a   Koshimura, Jun ^a   Fujita, Hiroki ^a   Kakei, Masafumi ^a   Ito, Seike ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CERULOPLASMIN; CREATININE; IMMUNOGLOBULIN G; OROSOMUCOID; TRANSFERRIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMOALBUMINURIA; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

ADULT; ALBUMINURIA; BODY MASS INDEX; CERULOPLASMIN; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; OROSOMUCOID; REFERENCE VALUES; REGRESSION ANALYSIS; TRANSFERRIN;

EID: 2342460511     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.5.1176     Document Type: Article

References (31)

1. Excerpts from the USRDS 2000 Annual Data Report: International comparison. Am J Kidney Dis 30:S177-S182, 2000
2. Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M: Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100-106, 1988
3. Jerums G, Allen TJ, Cooper ME: Triphasic changes in selectivity with increasing proteinuria in type 1 and type 2 diabetes. Diabet Med 6:772-779, 1989
4. Narita T, Fujita H, Koshimura J, Meguro H, Kiatazto H, Shimotomai T, Kagaya E, Suzuki K, Murata M, Usami A, Ito S: Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria. Horm Metab Res 33:370-378, 2001
5. O'Donnel MJ, Martin P, Florkowski CM, Toop MJ, Chapman C, Holder R: Urinary excretion of transferrin excretion in type I (insulin-dependent) diabetes mellitus. Diabet Med 8:657-661, 1991
6. Cheung CK, Cockram CS, Yeung VFT, Schwaminathan R: Urinary excretion of transferrin in non-insulin-dependent diabetics: a marker for early complications. Clin Chem 35:1672-1674, 1989
7. McCormick CP, Konen JC, Shihabi ZK: Microtransferrinuria and microalbuminuria: I. In the diabetic human. Clin Physiol Biochem 8:53-58, 1990
8. Bernard AM, Ouled Amor AA, Goemaere-Vanneste J, Antonie JL, Lauwerys RR, Lambert A, Vandeleene B: Microtransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria. Clin Chem 34:1920-1921, 1988
9. Yamazaki M, Ito S, Usami A, Tani N, Hanyu O, Nakagawa O, Nakamura H, Shibata A: Urinary excretion rate of ceruloplasmin in non-insulin dependent diabetic patients with different stage of nephropathy. Eur J Endocrinol 132:681-687, 1995
10. Ito S, Tsuda A, Momotsu T, Igarashi K, Kasahara S, Satoh K, Shibata A: Urinary orosomucoid excretion rate in patients with rion-insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 120:584-590, 1989
11. Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G: Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes. Diabetes Care 22:1176-1180, 1999
12. Narita T, Kitazato H, Koshimura J, Suzuki K, Murata M, Ito S: Effects of protein meals on the urinary excretion of various plasma proteins in healthy subjects. Nephron 81:398-405, 1999
13. Fujita H, Narita T, Ito S: Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance. Diabetes Care 22:823-826, 1999
14. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375-380, 1982
15. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82:5963-5967, 1985
16. Anderson S, Brenner BM: Pathogenesis of diabetic nephropathy: hemodynamic considerations. Diabetes Metab Rev 4: 163-177, 1988
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1195, 1997
18. 2-macroglobulin. Tohoku J Exp Med 176: 137-147, 1995
19. Brodows RG, Nichols D, Shaker G, Kubasik NP: Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care 9:189-193, 1986
20. Narita T, Koshimura J, Suzuki K, Murata M, Meguro H, Fujita H, Kitazato H, Ito S: Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med 189:117-133, 1999
21. Nakamura Y, Myers BD: Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37:1202-1211, 1988
22. Pietravalle P, Morano S, Cristina G, De Rossi MG, Mariani G, Cotroneo P, Ghirlanda G, Clementi A, Andreani D, Di Mario U: Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 40:1685-1690, 1991
23. Deckert T, Kofoed-Enevoldsen A, Vidal P, Nørgaard K, Andreasen HB, Feldt-Rasmussen B: Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36: 244-251, 1993
24. Myers BD, Winetz JA, Chui F, Michaels AS: Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function. Kidney Int 21:633-641, 1982
25. Tomlanovich S, Deen WM, Jones HW III, Schwartz HC, Myers BD: Functional nature of the glomerular injury in progressive diabetic glomerulopathy. Diabetes 36:556-565, 1987
26. Scandling JD, Myers BD: Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 41: 840-846, 1992
27. Deen WM, Bridges CR, Brenner BM, Myers BD: Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. Am Physiol 249: F374-F389, 1985
28. Myers BD: Pathophysiology of proteinuria in immune glomerular injury. Am J Nephrol 10:19-23, 1990
29. Tencer J, Frick IM, Öqvist B, Alm P, Rippe B: Size selectivity of the glomerular barrier to high molecular weight proteins: the upper size limitation of the shunt pathways. Kidney Int 53:709-715, 1998
30. Hoogenberg K, Sluiter WJ, Navis G, Van Haeften TW, Smit AJ, Reitsma WD, Dullaart RPF: Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus. J Am Soc Nephrol 9:643-654, 1998
31. Verroust PJ, Kozyraki R: The roles of cubilin and megalin, two multiligand receptors, in proximal tubule function: possible implication in the progression of renal disease. Curr Opin Nephrol Hypertens 10:33-38, 2001